Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Use of parasympatholytics.

D Berdel, A V Berg

    Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi [Journal]. Zhonghua Minguo Xiao Er Ke Yi Xue Hui
    |November 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Parasympatholytics like ipratropium are effective asthma treatments, particularly for infants and children. These drugs block receptors to reduce airway constriction, offering benefits even with improper inhalation techniques.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [The life quality of the disabled as a result of diseases of peripheral nervous system].

    Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny·2022
    Same author

    [The social economic aspects of disability resulted from diseases of peripheral nervous system].

    Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny·2022
    Same author

    [Guideline for the Diagnosis and Treatment of Asthma - Addendum 2020 - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology].

    Pneumologie (Stuttgart, Germany)·2021
    Same author

    Adrenal insufficiency is a contraindication for omalizumab therapy in mast cell activation disease: risk for serum sickness.

    Naunyn-Schmiedeberg's archives of pharmacology·2020
    Same author

    [Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology].

    Pneumologie (Stuttgart, Germany)·2018
    Same author

    The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolyzed infant formulas in infants at high risk for allergic diseases. Design and selected results.

    Allergologie select·2018

    Area of Science:

    • Pharmacology
    • Respiratory Medicine
    • Clinical Therapeutics

    Background:

    • The vagus nerve plays a significant role in bronchial asthma, suggesting parasympatholytic agents as potential therapeutic options.
    • Parasympatholytics, such as ipratropium and oxitropium bromide, function by blocking cholinergic (muscarinic) receptors in bronchial smooth muscle.
    • These agents inhibit cholinergic bronchomotor tone, a key factor in asthma pathophysiology.

    Purpose of the Study:

    • To evaluate the efficacy of parasympatholytics as antiasthmatic drugs, especially in pediatric populations.
    • To compare the effectiveness of parasympatholytics with beta-2-adrenergics in managing asthma.
    • To assess the impact of inhalation technique on the therapeutic outcomes of parasympatholytics.

    Main Methods:

    Related Experiment Videos

  • Review of current literature on parasympatholytic drugs in asthma therapy.
  • Analysis of receptor blockade mechanisms (cholinergic/muscarinic) by ipratropium and oxitropium bromide.
  • Comparison of bronchodilator effects with beta-2-adrenergics.
  • Evaluation of efficacy in infants and small children.
  • Assessment of antiobstructive effects irrespective of inhalation technique.

    • Main Results:

    • Parasympatholytics are potent antiasthmatic drugs, demonstrating particular effectiveness in infants and small children.
    • While generally less potent bronchodilators than beta-2-adrenergics, they offer significant antiasthmatic benefits.
    • Effective antiobstructive effects were observed even when parasympatholytics were administered via oral spray, bypassing the need for precise inhalation technique.
    • Beta-2-adrenergics may be less effective in very young children compared to parasympatholytics.

    Conclusions:

    • Parasympatholytics represent a valuable therapeutic class for managing bronchial asthma, especially in pediatric patients.
    • The clinical utility of parasympatholytics is highlighted for individuals, including infants and children, who struggle with proper inhaler use.
    • These findings underscore the importance of considering parasympatholytics in asthma treatment algorithms, particularly when optimal inhalation delivery is a challenge.